Description
PRODUCT OVERVIEW
Four Peptide Components in One Research Blend
KLOW combines four distinct research peptides:
· GHK-Cu (50mg): A copper-binding tripeptide studied in relation to extracellular matrix biology, copper coordination, and cellular signaling.
· BPC-157 (10mg): A synthetic pentadecapeptide investigated primarily in preclinical studies involving cellular and tissue-related biological processes.
· TB-500 (10mg): A commercial research peptide designation associated with thymosin beta-4-related research. The exact molecular identity should be confirmed against supplier documentation.
· KPV (10mg): A tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone, investigated in research involving cellular signaling and inflammatory pathways.
KLOW is a blend rather than a single molecular compound. The individual peptides have different structures and research profiles, and findings involving any one component do not establish the properties or effects of the complete formulation.
PRODUCT SPECIFICATIONS
| Specification | Details |
| Product Name | KLOW 80mg |
| Compound Classification | Four-component peptide blend |
| GHK-Cu | 50mg |
| BPC-157 | 10mg |
| TB-500 | 10mg |
| KPV | 10mg |
| Total Labeled Quantity | 80mg |
| Price | $99.00 |
| Purity | Refer to applicable product and lot documentation |
| Batch Identification | Where provided |
| Supporting Documentation | Applicable product or lot documentation |
Confirm the stated composition and molecular identities against the supplier’s current specifications and applicable COA before publication.
SCIENTIFIC BACKGROUND
The four components in KLOW represent distinct areas of peptide research.
GHK-Cu has been studied for its copper-binding properties and interactions associated with extracellular matrix biology. BPC-157 has primarily been investigated in preclinical experimental models. Thymosin beta-4-related research has examined cellular migration and actin-associated processes, while KPV has been investigated in experimental studies involving cellular signaling and inflammatory pathways.
These findings relate to individual compounds and specific experimental conditions. Evidence for the separate ingredients does not establish the effectiveness, safety, or combined biological activity of KLOW itself. Research specifically evaluating this exact four-component formulation remains limited.
RESEARCH APPLICATIONS
KLOW 80mg may be examined in controlled laboratory settings for:
· Multi-Component Characterization: Evaluation of the reported identity and analytical properties of the blend’s individual components.
· Peptide-Metal Research: Investigation of copper coordination associated with GHK-Cu.
· Cellular Signaling Research: Examination of published findings associated with the individual peptide components.
· Comparative Peptide Analysis: Evaluation of differences between individual peptide materials and a combined preparation.
· Composition Assessment: Review of the stated component quantities and total labeled content.
· Analytical Documentation: Comparison of product specifications, reported purity, and available batch-specific findings.
These applications describe potential scientific research areas and do not establish clinical benefits or product-specific biological effects.
QUALITY & LABORATORY DOCUMENTATION
Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.
Researchers should review the available documentation for component identity, reported purity, analytical methods, laboratory information, and batch identification, where provided. For a multi-component preparation, documentation should identify the relevant components and correspond to the specific product lot being evaluated.
LOT & BATCH REFERENCE
Where a lot number or batch identifier is provided, retain it with the corresponding laboratory documentation. This supports traceability and helps researchers associate analytical findings with the relevant blend.
STORAGE & HANDLING
Store and handle KLOW 80mg according to the supplier-provided specifications and applicable laboratory procedures. Refer to the product-specific documentation for storage conditions, packaging requirements, and handling precautions.
RESEARCH USE STATEMENT
KLOW 80mg is offered strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.
IMPORTANT NOTICE
KLOW is a commercial blend designation, not the scientific name of a single peptide. The stated formulation should be verified against applicable product specifications and batch documentation before research use. No claim is made that this product is approved for human use or has established clinical benefits.

Reviews
There are no reviews yet.